Business

Cough Syrup Exporters Require to undertake Testing at Govt Labs For Outbound Shipments

From June 1, cough syrup exporters will need to test their products at specific government laboratories before obtaining approval for outbound shipments. The shift in the trajectory came after after India-made cough syrups that were connected to dozens of deaths in the Gambia and Uzbekistan in 2002, the decision to implement quality checks before export was made.

The Directorate General of Foreign Trade (DGFT) stated in a notification on Monday, “The export of cough syrup shall be permitted to be exported subject to export samples being tested and production of a certificate of analysis issued by any of the laboratories, with effect from June 1, 2023.”

The NABL (National Accreditation Board for Testing and Calibration Laboratories) accredited drug testing labs of state governments are included among the specified central government labs, along with the Pharmacopoeia Commission, regional drug testing labs (RDTL – Chandigarh), central drugs labs (CDL – Kolkata), central drug testing labs (CDTL – Chennai Hyderabad, Mumbai), and RDTL (Guwahati).

The syrups, produced by the Indian company Maiden Pharmaceuticals Ltd., were found to contain the deadly toxins ethylene glycol (EG) and diethylene glycol (DEG), which are also found in brake fluid. Unreliable actors may substitute these ingredients for propylene glycol (PG), a crucial component of syrupy medicines.

Global Pharma Healthcare, based in Tamil Nadu, recalled its entire batch of eye drops in February.  In 2022–2023, India exported cough syrups worth US$17.6 billion, up from US$17 billion in the 2021–2022 period.

The LMIC (low and middle-income countries) and highly developed nations alike purchase medical products from the Indian pharmaceutical industry, which is a significant global manufacturer and exporter of pharmaceuticals. India is the world’s largest supplier of generic drugs, meeting more than 50% of the demand for various vaccines globally, about 40% of generic drug demand in the US, and about 25% of all medicine demand in the UK.

India is the third-largest pharmaceutical producer in the world by volume and the fourteenth-largest by value. There are about 10,500 manufacturing facilities and a network of 3,000 pharmaceutical companies in this sector. It makes it easier for high-quality, reasonably priced, and easily accessible medicines to be supplied and made available globally. India holds a significant position in the world’s pharmaceutical industry.

Currently, Indian pharmaceutical companies provide over 80% of the antiretroviral drugs used to combat AIDS worldwide.

 

Malika Sahni

Recent Posts

India Achieves Historic Milestone In Child Immunisation; Sets Global Benchmark

India has made a historic leap in child immunisation by reducing the percentage of zero-dose…

3 mins ago

India’s Automotive Industry Gears Up To Power $5 Trillion Economy

India's auto sector powers economic growth with rising EV adoption, strong exports, and major policy…

12 mins ago

India’s Cement Industry Posts 9% Volume Growth In May 2025; Price Hikes Aid Margins

India’s cement sector saw a 9% YoY rise in volumes in May 2025 and higher…

15 mins ago

Foreign Portfolio Investors Infuse Over ₹13,000 Crore Into Indian Markets In One Week

FPIs invested over ₹13,000 crore in Indian markets last week, driven by global stability, RBI…

34 mins ago

Char Dham Yatra Suspended For 24 Hours Due To Torrential Rain

Uttarakhand halts Char Dham Yatra for 24 hours amid heavy rains and landslides. Authorities warn…

45 mins ago

PM Modi Condemns Emergency Era; Calls It Assault On Democracy

Prime Minister Narendra Modi, in the 123rd edition of his radio programme ‘Mann Ki Baat’,…

57 mins ago